eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank

4/2019
vol. 11
 
Share:
Share:
abstract:
Case report

Placement of 131Cs permanent brachytherapy seeds in a large combined cavity of two resected brain metastases in one setting: case report and technical note

Jacelyn Greenwald
1
,
Shoshana Taube
2
,
Menachem Z. Yondorf
2
,
Andrew Smith
2
,
Albert Sabbas
2
,
A. Gabriella Wernicke
2, 3

  1. Cornell University College of Arts and Sciences, Ithaca, New York, United States
  2. Stich Radiation Oncology, Weill Cornell Medical College/New York-Presbyterian Hospital, New York, NY, United States
  3. Department of Neurosurgery, Brain and Spine Center, Weill Cornell Medical College/New York-Presbyterian Hospital, New York, NY, United States
J Contemp Brachytherapy 2019; 11, 4: 356–360
Online publish date: 2019/08/29
View full text Get citation
 
Large brain metastases are presently treated with surgical resection and adjuvant radiotherapy. However, local control (LC) for large tumors decreases from over 90% to as low as 40% as the tumor/cavity increases. Intraoperative brachytherapy is one of the focal radiotherapy techniques, which offers a convenient option of starting radiation therapy immediately after resection of the tumor and shows at least an equivalent LC to external techniques. Our center has pioneered this treatment with a novel FDA-cleared cesium-131 (131Cs) radioisotope for the resected brain metastases, and published promising results of our prospective trial showing superior results from 131Cs application to the large tumors (90%). We report a 57-year-old male patient, with metastatic hypopharyngeal brain cancer. The patient presented with two metastases in the right frontal and right parietal lobes. Post-resection of these lesions resulted in a large total combined cavity diameter of 5.3 cm, which was implanted with 131Cs seeds. The patient tolerated the procedure well, with 100% local control and 0% radiation necrosis. This case is unique in demonstrating that the 131Cs isotope was not only a convenient option of treating two resected brain metastases in one setting, but also that this treatment option offered excellent long-term LC and minimal toxicity rates.
keywords:

cesium-131, 131Cs, brachytherapy, metastasis, radiation, radiotherapy

 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.